台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    67.5
  • 漲跌
    ▼0.2
  • 漲幅
    -0.30%
  • 成交量
    30
  • 產業
    上櫃 生技醫療類股▼0.76%
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-統一-宜蘭 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

統一-宜蘭 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/0600.00165.8065.90-1206-0.49%
2023/10/1900.000.727.6728.30-0.779-0.88%
2023/05/2400.00221.5521.65-2112-1.77%
2021/03/0200.00419.0017.40-4256-1.56%
2021/02/26417.48118.1518.1532301.30%
2021/02/2300.00318.3017.45-3193-1.55%
2021/02/19115.0500.0016.0011710.58%
2020/12/2100.00617.2017.05-6348-1.72%
2020/12/16617.3000.0017.4563491.72%
2020/11/19318.9000.0019.0033840.78%
2020/11/1000.00120.2020.20-1420-0.24%
2020/11/03118.5500.0018.6014560.22%
2020/10/28319.3000.0019.0035090.59%
2020/10/2200.00220.8521.20-2561-0.36%
2020/10/21221.75221.4821.7505440.00%
2020/10/1900.00217.5018.00-2557-0.36%
2020/10/15214.9000.0014.9526330.32%
2020/08/20219.7800.0019.7022,1210.09%
2020/08/1100.00123.0522.60-12,322-0.04%
2020/08/03125.70126.4026.4002,2730.00%
2020/07/29125.4000.0025.5512,2730.04%
2020/07/1600.00129.3029.05-12,018-0.05%
2020/07/15130.3000.0030.8011,9830.05%
2020/07/1300.000.331.5531.55-0.31,793-0.02%
2020/06/1600.00525.1025.90-51,294-0.39%
2020/06/11520.9500.0021.0051,0770.46%
2020/06/1000.00318.2519.10-3985-0.30%
2020/06/0800.00118.0018.00-1946-0.11%
2020/06/0500.00117.3017.30-1945-0.11%
2020/05/28518.5000.0018.5059780.51%
2020/05/2200.00117.9017.90-1930-0.11%
2020/04/2700.00310.5010.55-3702-0.43%
2020/04/2439.7100.009.6036960.43%
2020/03/0200.00414.6014.60-4397-1.01%
2019/10/0400.000.410.8010.85-0.4146-0.28%
2019/07/1100.00210.7510.55-299-2.02%
2019/07/09210.2500.0010.252972.05%
2019/04/2200.00512.2512.15-5142-3.50%
2019/04/12512.5000.0012.4551593.13%
2019/03/1500.00413.3012.90-4145-2.76%
2019/03/14413.2500.0013.4041382.89%
2019/03/1100.00212.5012.45-2130-1.53%
2019/03/08212.4000.0012.4021301.53%
2019/01/0900.00211.7511.60-267-2.98%
2019/01/08212.0000.0012.202613.24%
2019/01/0200.00111.1011.10-160-1.66%
2018/12/26111.6000.0011.151621.59%
2018/12/2000.00311.3011.20-364-4.68%
2018/12/18311.6000.0011.303644.66%
2018/11/0500.00211.5011.70-290-2.21%
2018/11/02211.7000.0011.652902.21%
2018/10/0500.00315.9815.95-3110-2.72%
2018/10/0300.00116.6016.15-1114-0.87%
2018/09/2800.00316.7016.50-3115-2.60%
2018/09/26216.85317.0016.85-1117-0.85%
2018/09/25216.9500.0016.8021171.70%
2018/09/2000.00216.7016.70-2117-1.70%
2018/09/1400.00316.9016.90-3120-2.49%
2018/09/12217.05217.1016.8501210.00%
2018/09/101118.2200.0018.45111129.80%
2018/08/2200.00316.9017.10-3115-2.61%
2018/08/21317.2000.0017.2031162.58%
2018/08/1700.00217.5017.05-2119-1.67%
2018/08/1400.00317.7317.90-3118-2.53%
2018/08/13218.00618.4818.00-4119-3.34%
2018/08/10918.8700.0018.7591207.47%
2018/07/1300.001119.0017.95-11158-6.93%
2018/07/121117.9800.0018.40111646.67%
2018/06/2200.00217.6517.55-2399-0.50%
2018/06/21218.0000.0017.9524000.50%
2018/06/1200.00118.0018.10-1397-0.25%
2018/06/08118.40418.0518.45-3396-0.76%
2018/06/0100.00218.5018.35-2393-0.51%
2018/05/2300.00218.2018.10-2399-0.50%
2018/05/1800.00218.5018.25-2398-0.50%
2018/05/1000.00118.6018.60-1396-0.25%
2018/05/04118.7500.0018.9513860.26%
2018/05/0200.00119.6019.60-1380-0.26%
2018/04/3000.00119.8519.55-1378-0.26%
2018/04/27419.5500.0019.6043771.06%
2018/04/26220.4000.0019.7023750.53%
2018/04/16521.6800.0021.3553291.52%
2018/04/1300.00223.0023.70-2302-0.66%
2018/04/12222.10223.0022.0002490.00%
2018/04/11522.64322.9322.9022320.86%
2018/04/10322.851222.8522.85-9189-4.74%
2018/04/091220.4300.0020.80121259.58%
2018/04/0300.00518.6018.95-5118-4.24%
2018/03/3000.00119.1518.80-1161-0.62%
2018/03/29619.2200.0019.1561783.37%
2018/03/2800.00118.9018.90-1183-0.55%
2018/03/2700.00119.7519.00-1186-0.54%
2018/03/26219.7000.0019.7021871.07%
2018/03/1900.001319.2619.55-13187-6.93%
2018/03/16319.8500.0019.5531861.61%
2018/03/0900.00119.0019.00-1187-0.53%
2018/03/08119.1500.0018.8511870.53%
2018/03/071019.2300.0018.90101865.35%
2018/02/2300.00918.9119.30-9203-4.42%
2018/02/22918.2400.0018.7591964.58%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音